Protagonist Therapeutics - 53 Year Dividend History | PTGX
Historical dividend payout and yield for Protagonist Therapeutics (PTGX) since 1971. The current TTM dividend payout for Protagonist Therapeutics (PTGX) as of April 19, 2024 is $0.00. The current dividend yield for Protagonist Therapeutics as of April 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.470B |
$0.060B |
|
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
